MannKind | MNKD - Pe Prix À Revenus





Pe Changement Date
Adma Biologics 29.73 12.48 2025-12
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
Eli Lilly 40.27 0.06 2026-03
Halozyme Therapeutics 11.35 11.8 2026-03
MannKind 201.15 102.55 2026-03
Merck 16.52 2.6 2026-03
Novavax 2.01 1.07 2025-12
Novo Nordisk 13.92 4.91 2025-09
Pfizer 9.32 5.16 2026-03
Sanofi 11.84 0.14 2026-03
Xencor 29.92 3.22 2022-09